Why the formulary is the first thing to check
Before you and your prescriber can navigate prior authorization, step therapy, or appeals, there's a more basic question: is the medication on your plan's formulary at all, and if so, at what cost tier? This is the single most useful piece of information to gather before starting the GLP-1 conversation with your doctor, because it shapes almost everything that follows — what you'll pay, what paperwork is required, and whether alternative medications might be an easier path to coverage. This guide walks through how to actually check, and explains who decides what's on that list in the first place. For the broader picture of how coverage decisions work end-to-end, see our guide on understanding insurance coverage for GLP-1 medications.
How to check your formulary
- Log into your insurance member portal. Most insurers post a searchable formulary or "drug list" directly on their website once you log in — search for the specific drug name (e.g., "semaglutide," "Wegovy," "Zepbound," "tirzepatide") rather than just "GLP-1," since formularies are organized by drug name, not drug class.
- Call the number on your insurance card. If you can't find or navigate the online tool, member services can look up formulary status and tier directly — ask specifically: "Is [drug name] on my formulary, what tier, and does it require prior authorization or step therapy?"
- Ask your pharmacy to run a test claim. Pharmacies can often submit a trial claim before you have a prescription in hand, which will return a real-time coverage and cost estimate — useful because it reflects your plan's actual current rules, not just the general formulary listing.
- Check with your employer's HR or benefits team, if you have employer-sponsored insurance. Some employers specifically carve out or exclude GLP-1 coverage for weight management regardless of what the insurer's standard formulary says — see our discussion guide on talking to your employer about GLP-1 coverage.
- Ask your prescriber's office. Practices that prescribe GLP-1 medications frequently often have staff experienced in checking formulary status and initiating prior authorization, and may be able to tell you quickly based on your insurance plan.
What you're looking for once you find it
- Is it listed at all? Some formularies exclude GLP-1 medications for weight management entirely, while covering the same drug for diabetes.
- What tier is it on? Formularies typically use tiers (e.g., Tier 1 = generic, Tier 2-3 = preferred/non-preferred brand, Tier 4+ = specialty) that determine your copay or coinsurance. GLP-1 medications are often placed in higher, more expensive tiers.
- Are there restrictions attached? Look for flags like prior authorization or step therapy requirements next to the drug listing — these determine what documentation or prior treatment history is needed before approval.
- Is there a preferred alternative? Formularies sometimes favor one GLP-1 drug over another (e.g., covering tirzepatide but not semaglutide, or vice versa) based on the PBM's negotiated pricing — worth knowing before you and your prescriber settle on a specific medication.
How a formulary is chosen, and by whom
A formulary isn't set by your doctor, and often isn't fully controlled by your insurance company either. Here's who's actually involved:
Pharmacy Benefit Managers (PBMs). Most formulary construction is done or heavily influenced by PBMs — third-party companies (such as CVS Caremark, Express Scripts, or OptumRx) that insurers and employers contract with to manage prescription drug benefits. PBMs negotiate rebates and discounts directly with drug manufacturers, and those negotiated deals significantly influence which drugs get preferred placement on a formulary — a lower list price alone doesn't guarantee formulary preference if a competing drug offers a better negotiated rebate.
Pharmacy and Therapeutics (P&T) Committees. Formulary decisions are formally made by a P&T committee — a group typically composed of physicians, pharmacists, and other clinical experts, convened either by the PBM, the insurer, or a large employer's benefits consultant. The committee reviews clinical evidence (efficacy, safety, comparative effectiveness) for each drug being considered, alongside cost data, and votes on formulary placement and tier.
Insurers. Health plans set the overall structure of the formulary (number of tiers, cost-sharing amounts) and may adopt a PBM's recommended formulary wholesale, or modify it based on their own priorities.
Employers (for employer-sponsored plans). Self-funded employers — companies that pay their employees' healthcare costs directly rather than fully outsourcing to an insurer — often have significant say over their specific plan's formulary, including the ability to exclude entire drug categories like weight-management GLP-1s even if the insurer's standard formulary includes them. This is why two people with the "same" insurance company but different employers can have very different GLP-1 coverage.
Manufacturers, indirectly. While drug manufacturers don't sit on P&T committees, their pricing and rebate offers to PBMs are a major factor in the committee's cost-effectiveness analysis — which is part of why formulary placement can shift year to year as manufacturers compete for preferred status.
The bottom line
Formulary status isn't fixed or universal — it varies by insurer, by PBM, and often by your specific employer's plan design, and it can change annually. Checking your formulary directly (not assuming based on what a friend's plan covers) is the necessary first step before pursuing prior authorization, step therapy documentation, or an appeal.